NCT01434160 - LCS12 Adolescent Study | Biotech Hunter

Enrollment

304

Participants

Timeline

Start Date

September 30, 2011

Primary Completion Date

June 30, 2013

Study Completion Date

May 31, 2015

Conditions

Contraception

Interventions

DRUG

Skyla (Levonorgestrel, BAY86-5028)

Levonorgestrel intrauterine contraceptive system (LCS12) insertion into the uterus at insertion visit 2 with the study treatment of 12 months. An optional follow up phase up to 3 years will be offered for all subjects completing 12 month treatment time.

Trial Locations (41)

1020

Bruxelles - Brussel

1070

Vienna

1090

Bruxelles - Brussel

1364

Fornebu

1653

Sellebakk

2018

Antwerp

2300

København S

3000

Leuven

3100

Sankt Pölten

6000

Charleroi

6900

Bregenz

8570

Voitsberg

8740

Zeltweg

21073

Hamburg

22587

Hamburg

38889

Blankenburg

50931

Cologne

59590

Geseke

70110

Kuopio

75185

Uppsala

90100

Oulu

90220

Oulu

91054

Erlangen

DK-8000

Århus C

DK-2400

København NV

00100

Helsinki

00610

Helsinki

01744

Dippoldiswalde

01169

Dresden

04207

Leipzig

04299

Leipzig

1817 MS

Alkmaar

Unknown

Almere Stad

Enschede

Heerlen

Tilburg

1780 AT

Den Helder

3435 CM

Nieuwegein

411 18

Gothenburg

118 83

Stockholm

171 76

Stockholm